高用量組換えインターロイキン-2療法を受けた転移性腎細胞癌患者255名の治療成績。

Fyfeら（Wed，）がこの問題を検討した。

www.synapsesocial.com/papers/69d7c01a3b601d7be3ae2af2 — DOI: https://doi.org/10.1200/jco.1995.13.3.688

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.· 1985 · 741 citations
2. Structure and expression of a cloned cDNA for human interleukin-2· 1983 · 1,186 citations
3. Biologic response modifiers in the therapy of metastatic renal cell carcinoma.· 1988 · 35 citations
4. Acute Thyroid Dysfunction (Thyroiditis) after Therapy with Interleukin-2· 1992 · 46 citations
5. The natural history and clinical features of renal carcinoma.· 1987 · 105 citations